Thus, CDKN2AIP is a positively regulated F3T which is lost in HD cells and could decrease p14ARF activity in these cells, potentially promoting cellular vulnerability (Wadhwa, Kalra, & Kaul, 2017). This evidence concerns the gene CDKN2AIP and Huntington disease.